Literature DB >> 21925615

Spatial organization of intracellular Ca2+ signals.

Vera Konieczny1, Michael V Keebler, Colin W Taylor.   

Abstract

The ability of Ca(2+), the simplest of all intracellular messengers, selectively to regulate so many cellular behaviours is due largely to the complex spatiotemporal organization of intracellular Ca(2+) signals. Most signalling pathways, including those that culminate in Ca(2+) signals, comprise sequences of protein-protein interactions linked by diffusible messengers. Using specific examples to illustrate key principles, we consider the roles of both components in defining the spatial organization of Ca(2+) signals. We discuss evidence that regulation of most Ca(2+) channels by Ca(2+) contributes to controlling the duration of Ca(2+) signals, to signal integration and, via Ca(2+)-induced Ca(2+) release, to defining the spatial spread of Ca(2+) signals. We distinguish two types of protein-protein interaction: scaffolds that allow rapid local transfer of diffusible messengers between signalling proteins, and interactions that directly transfer information between signalling proteins. Store-operated Ca(2+) entry provides a ubiquitous example of the latter, and it serves also to illustrate how Ca(2+) signals can be organized at different levels of spatial organization - from interactions between proteins to interactions between organelles.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21925615     DOI: 10.1016/j.semcdb.2011.09.006

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  16 in total

1.  CaBP1, a neuronal Ca2+ sensor protein, inhibits inositol trisphosphate receptors by clamping intersubunit interactions.

Authors:  Congmin Li; Masahiro Enomoto; Ana M Rossi; Min-Duk Seo; Taufiq Rahman; Peter B Stathopulos; Colin W Taylor; Mitsuhiko Ikura; James B Ames
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

2.  Padé Approximation of a Stationary Single-Channel Ca2+ Nanodomain.

Authors:  V Matveev
Journal:  Biophys J       Date:  2016-11-01       Impact factor: 4.033

3.  Calcium affects OX1 orexin (hypocretin) receptor responses by modifying both orexin binding and the signal transduction machinery.

Authors:  Jaana Putula; Tero Pihlajamaa; Jyrki P Kukkonen
Journal:  Br J Pharmacol       Date:  2014-11-05       Impact factor: 8.739

4.  Efficient Approximations for Stationary Single-Channel Ca2+ Nanodomains across Length Scales.

Authors:  Yinbo Chen; Cyrill B Muratov; Victor Matveev
Journal:  Biophys J       Date:  2020-08-14       Impact factor: 4.033

5.  Extension of Rapid Buffering Approximation to Ca2+ Buffers with Two Binding Sites.

Authors:  Victor Matveev
Journal:  Biophys J       Date:  2018-03-13       Impact factor: 4.033

Review 6.  Targeting Bcl-2-IP3 receptor interaction to treat cancer: A novel approach inspired by nearly a century treating cancer with adrenal corticosteroid hormones.

Authors:  Clark W Distelhorst
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-07-25       Impact factor: 4.739

Review 7.  Orexin/hypocretin receptor signalling cascades.

Authors:  J P Kukkonen; C S Leonard
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

8.  Hindered cytoplasmic diffusion of inositol trisphosphate restricts its cellular range of action.

Authors:  George D Dickinson; Kyle L Ellefsen; Silvina Ponce Dawson; John E Pearson; Ian Parker
Journal:  Sci Signal       Date:  2016-11-08       Impact factor: 8.192

9.  IP3 mediated global Ca2+ signals arise through two temporally and spatially distinct modes of Ca2+ release.

Authors:  Jeffrey T Lock; Ian Parker
Journal:  Elife       Date:  2020-05-12       Impact factor: 8.140

Review 10.  Intracellular calcium channels: inositol-1,4,5-trisphosphate receptors.

Authors:  Olena A Fedorenko; Elena Popugaeva; Masahiro Enomoto; Peter B Stathopulos; Mitsuhiko Ikura; Ilya Bezprozvanny
Journal:  Eur J Pharmacol       Date:  2013-12-01       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.